Gianpaolo Pozzato on Advancing Hemostasis Automation Through HemoCell and Axonlab Collaboration
Gianpaolo Pozzato, EEMEA Hemostasis Product Manager, shared on LinkedIn:
”Kicked off 2026 with a focused visit to Basel, Switzerland, returning to our HemoCell installation to further optimize performance and resilience.
Why the Werfen dedicated, specialized automation matters in Hemostasis:
– Consistent, standardized workflows
– Reliable TAT even at peak load
– Strong QC, full traceability, and smart reflex testing
This trip was about aligning system capabilities with the evolving complexity of Hemostasis workloads, and translating user feedback into measurable operational gains.
Grateful to Daria Prokudina, MD for the expert on‑site support, and to our Partner Axonlab international for the excellent collaboration and hospitality.
Together we keep raising the bar for patient‑centric diagnostics.”
Stay updated with Hemostasis Today.
-
Jun 27, 2026, 01:31Alessio De Rose: Addressing Micronutrient Deficiencies in the Era of GLP-1 Receptor Agonists
-
Jun 27, 2026, 01:21Michelle Sámano Sánchez: Exploring Vitamin C as an Adjunct Therapy for Anemia in Hemodialysis
-
Jun 27, 2026, 01:08Ana Raquel Gotine: The First Pragmatic Clinical Trial on MNPs and Childhood Anemia in Mozambique
-
Jun 27, 2026, 00:56Sherif Badawy: Reflecting on My Time with ASH CRTI
-
Jun 27, 2026, 00:48Zain Khalpey: Why High quality CPR is Only Part of Successful Cardiac Arrest Management
-
Jun 26, 2026, 22:31Wendy Dusenbury: The New Issue of the Stroke Clinician is Now Live
-
Jun 26, 2026, 20:42Ed Watson: When It Happens to You, Stroke Becomes Personal, Immediate, and Life-Changing
-
Jun 26, 2026, 19:45Nathan Connell: Transforming Surgical Care with Tranexamic Acid
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?